SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001654954-18-001966
Filing Date
2018-02-28
Accepted
2018-02-28 16:27:23
Documents
55
Period of Report
2017-11-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT qbio_10k113017.htm 10-K 1359738
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex_31.htm EX-31.1 17792
3 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE ex_32.htm EX-32.1 7677
  Complete submission text file 0001654954-18-001966.txt   3691939

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT qbio-20171130.xml EX-101.INS 491560
5 XBRL TAXONOMY EXTENSION SCHEMA qbio-20171130.xsd EX-101.SCH 33983
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qbio-20171130_cal.xml EX-101.CAL 38630
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qbio-20171130_def.xml EX-101.DEF 71069
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE qbio-20171130_lab.xml EX-101.LAB 241442
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qbio-20171130_pre.xml EX-101.PRE 184087
Mailing Address 501 MADISON AVE. 14TH FLOOR NEW YORK NY 10022
Business Address 501 MADISON AVE. 14TH FLOOR NEW YORK NY 10022 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-K | Act: 34 | File No.: 000-55535 | Film No.: 18651634
SIC: 2834 Pharmaceutical Preparations